This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The Illinois Department of Public Health (IDPH), after confirming votes from the Medical Cannabis Advisory Board (MCAB), officially added four new conditions to the list of qualifying debilitating condition for Illinois patients in the Compassionate Use of Medical Cannabis Program.
During the last few months, the Illinois Department of Public Health (IDPH), in conjunction with the Medical Cannabis Advisory Board (MCAB), voted to add four new recommended conditions to list of qualifying debilitating condition for Illinois patients in the Compassionate Use of Medical Cannabis Program.
As medical cannabis emerges from the dark days of prohibition, researchers are finding a wide range of conditions responding successfully to it. Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states. Because cannabis is still a schedule 1 drug in the U.S.,
The signing of House Bill 1325 by Governor Abbott in 2019 legalized the cultivation of industrial hemp (cannabis containing less than 0.3% According to the Texas Government site, Texass Compassionate Use Program (CUP) allows certain physicians to prescribe low tetrahydrocannabinols (THC) cannabis for medical purposes.
Louisiana’s medical marijuana program may have been established three years ago, but patients were not granted access to medicine until August of 2019 when the first round of the product became available. Home cultivation remains illegal for the more than 4,000 registered medical marijuana patients. House Bill 819. House Bill 418.
House Bill 136, an amendment to legalize medical marijuana, was introduced in the Kentucky Legislature on Wednesday, January 9, 2019. Lawmakers have been listening to constituents suffering from debilitating diseases, like epilepsy and cancer, who say they would like to have the option to explore how medical cannabis may ease their symptoms.
The plan was initially passed in 2019 but was delayed multiple times, including because of the COVID-19 pandemic. Patients can take part if they have a medical condition which has not responded to pharmaceutical drugs. Children may be eligible in cases of refractory epilepsy or cancer.
Medical marijuana presents itself as a potential solution to this problem: With few side effects, and potential applications in treating a whole host of different conditions , marijuana may be a safer alternative to many of today’s most prescribed medications. WHAT IS POLYPHARMACY? With 35.8% WHO IS AFFECTED MOST?
As of 2019, the population in the state of Texas was estimated to be around 29 million and is rapidly growing as we speak. It allowed for low THC cannabis products for patients in Texas that had intractable epilepsy. In 2019 the law was updated thanks to HB 3703. Texas is known for doing it big. In recent news, HB 1535 advanced.
In recent years, lawmakers have eased up on a number of cannabis-derived formulations, and since 2015, people with epilepsy can obtain cannabis oil that contains less than 0.5% These products can be prescribed to a resident of the state by a medical physician that is qualified “with respect to a patient’s particular medical condition.”.
Despite notable advances in MMJ research over the last decade, scientists have found that some states’ restrictions on qualifying conditions prevent millions of patients from getting the treatments they need—robbing them of potential relief offered by cannabinoid therapies. Many patients take MMJ for more reasons than one.
The letter accused Curaleaf of “illegally selling unapproved products containing cannabidiol (CBD) online with unsubstantiated claims that the products treat cancer, Alzheimer’s disease, opioid withdrawal, pain and pet anxiety, among other conditions or diseases.”
Governor Jared Polis (D) of Colorado signed legislation into law that allows physicians to recommend medical cannabis for any condition for which an opiate would otherwise be prescribed. Legislation is pending, Senate Bill 236, to allow qualifying patients with certain debilitating conditions to use and safely access medical cannabis.
On Monday, March 18, 2019, Gov. Which conditions qualify for medical cannabis in Florida? Newly sworn-in Governor Ron DeSantis officially ended the statewide ban on smokable forms of medical cannabis in Florida, making good on the promise he made to patients. DeSantis signed Senate Bill 182 “Medical Use of Marijuana” into law.
— Senator Jay Costa (@Senatorcosta) February 15, 2019. To apply for a medical marijuana card in Pennsylvania, patients suffering from one of the qualifying conditions must first receive a recommendation from a state-licensed physician. Clearly this was a serious need in the Commonwealth.
Chad West March 27, 2019. Texas could make meaningful progress on marijuana-related bills by the end of the 2019 legislative session. The most promising step forward this session is probably an expansion of Compassionate Use to include more medical conditions that could be alleviated by cannabis. If passed, S.B. 1365 – Sen.
Cannabidiol ( CBD ), the non-psychoactive cannabinoid praised for medicinal powers like reducing the severity and frequency of seizures in children suffering from rare and otherwise untreatable forms of epilepsy, may not be the most medically beneficial molecule found in cannabis, according to new data. Data Tracking.
As medical cannabis emerges from the dark days of prohibition, researchers are finding a wide range of conditions responding successfully to it. Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states. Because cannabis is still a schedule 1 drug in the U.S.,
In September, the state expanded its list of qualifying conditions , allowing veterans with PTSD and cancer patients to join the program. Back in 2019 , the program was expanded to include ALL individuals with epilepsy—not just those with intractable epilepsy as the program had originally outlined.
Balkan Insight is reporting… eople with long-term illnesses are still being given prison sentences in Serbia for using cannabis to treat medical conditions, as the government has been stalling on legal reform while vowing even harsher anti-drug enforcement.
The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. The perception that CBD is a wonder-drug version of cannabis — particularly known for its uses to treat epilepsy — that doesn’t get you high. Shutterstock).
Individuals with this condition have to find ways to deal with the fact that their immune system is attacking the protective sheath of nerve fiber surrounding the nerve cells, putting the body in a state of imbalance that results in muscle spasms, paralysis, disrupted bladder function, mental changes, depression, and even epilepsy.
For specific conditions, cannabis prescriptions will become the purview of physicians and not require special dispensation from the Ministry of Health. Patients over the age of 18 (excepting children with severe epilepsy). Neurological indications such as epilepsy, Parkinson’s. Severe epilepsy in minors.
Warastuti is one of a group of Indonesian mothers who are urging the government to explore the drug’s remedial properties for various medical conditions, including chronic pain and cerebral palsy. In 14-year-old Pika’s case, there were no obvious signs of a medical condition when she was first born. Weighing 3.4
In a 2019 animal study, CBN isolate was reported to relieve musculoskeletal pain. CBN’s ability to target CB2 receptors, in comparison to THC (which prefers the CB1 receptor), gives it better credibility in treating autoimmune conditions such as rheumatoid arthritis, multiple sclerosis, and inflammatory bowel disease.
In 2019, Georgia’s General Assembly passed Georgia’s Hope Act, which legalized the regulated cultivation of marijuana in the State. Northwest Georgia News also revealed, “Separate from those dispensaries, the 2019 law also authorizes independent pharmacies to sell cannabis oil to eligible patients.”
It’ll open up the choices patients have available to them and they can purchase their medical marijuana to treat their condition,” said Executive Vice President of Grow Ohio Justin Hunt. “We Approximately 5,500 patients have purchased medical cannabis from a dispensary since the first day of legal retail sales began on January 16, 2019.
Individuals with qualifying medical conditions have since been able to register as patients with the Low THC Oil Registry and obtain cannabis oil containing no more than 5% of the psychoactive compound THC by weight. Sometime later, in July 2019, Georgia’s Hope Act (HB 324) , became effective.
Sales appear to have peaked in 2019, when natural channel consumers spent more than $90.7 Despite the companies’ submitting the required data demonstrating the “reasonable expectation of safety under the recommended conditions of use,” the FDA rejected the applications, citing the drug preclusion clause. Epilepsy Behav.
The program was legalized in 2015 and patients with qualifying conditions can get a prescription for up to 20oz of low THC oil, capsules, patches, or lotion. oz of 5% or less THC oil for medical patients with qualifying conditions. In-state cultivation and distribution weren’t legalized until 2019.
The bill was enacted as soon as Governor Nathan Deal signed it, permitting possession for eight qualifying medical conditions but not allowing cultivation or distribution within the state. In April 2019, House Bill 324 was approved, enabling in-state cultivation and the sale of low-THC oil.
The media storm came about as 12-year-old Billy Caldwell and 6-year-old Alfie Dingley were being denied cannabis oil as a treatment for their epilepsy. Naturally, this enraged the public since both of the children found failure in other medications before they found victory in cannabis as a treatment for their condition.
The availability of medications for patients varies from country to condition. These estimates vary drastically source to source, which reflects what conditions make a patient eligible for a cannabis-based medicine. Treatment options may be limited by government-approved imports, a practitioner’s prescription or pharmacy stock.
That said, research conducted to date has been promising, with CBD demonstrating the potential for aiding with a wide range of health conditions and resulting symptoms. Like humans, pets also feel anxiety, pain, and suffer from chronic conditions such as arthritis. Anxiety and Inflammation Lead the Pack.
Drug interactions reported in the scientific literature most often occur at very high doses used in clinical trials of epilepsy and other conditions. Glaucoma is still the first condition many people think of when they consider cannabis as a medicine. Epilepsy & behavior case reports 9 (2018): 10. CBD and Glaucoma.
Approximately 3,000 patients who suffer from debilitating conditions like chronic pain and epilepsy will partake in the project, which is due to end in March 2023. In November 2019, the founder of the world-famous circus Cirque du Soleil got tangled up in drug charges.
To some extent, cannabis has already been decriminalized for personal use in Israel since 2019, when a law went into effect that reduced the penalties for small-scale possession to a simple fine instead of criminal charges. Qualifying conditions for medical marijuana. What Israeli law permits for medical patients.
The study is titled A pediatric patient with autism spectrum disorder and epilepsy using cannabinoid extract as complementary therapy: A case report. For the study researchers studied the effects of marijuana extracts in a fifteen-year-old who suffered from autism, anxiety, and controlled epilepsy. ml twice daily. Case presentation.
For those of you in the dark about Florida’s Medical Marijuana Program, I will be lighting up the dim corners of Florida: The Nation’s Fastest-Growing Medical Marijuana Market , according to The Miami New Times on May 2, 2019. CANNABIS PRIMER. Glossary of Marijuana Terminologyvia CannaInsider.com. Americans for Safe Access.org.
[iii] The Act was originally intended for patients with intractable epilepsy and was expanded in 2019 and 2021 to include other physical and mental illnesses (cancer, multiple sclerosis, post-traumatic stress disorder). [iv] Specifically, H.B. Specifically, H.B.
Those state laws allow medical marijuana to be used to treat ailments like Alzheimer’s, cancer, epilepsy, Crohn’s disease, seizures, hepatitis C and a host of others. The United States Food and Drug Administration (FDA) has only cannabis use to treat two rare and severe forms of epilepsy: Dravet syndrome and Lennox-Gastaut syndrome.
T he EU has approved for the first time the use of a medicinal cannabis product aimed at patients with two rare, but severe, forms of childhood epilepsy. The medication, developed by GW Pharmaceuticals, will be used in combination with another epilepsy medication called clobazam. September 23, 2019. What do experts say?
Medical cannabis was started in 2021 under specific conditions in limited products only in Ireland (Shutterstock). In 2019, Ireland’s Minister for Health signed legislation to allow a pilot plan for medical cannabis, which launched in 2021 and is set to run for five years. reported previous cannabis use, but only 18.2%
In 2019, Fleury-Texeira et al. These are just two of the scientific studies proving the efficacy of CBD in treating various conditions. There are various conditions that, according to science, can be treated with Cannabigerol. Blessing et al., CBD as a treatment for Autism Spectrum Disorder. What is CBG?
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content